Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | 12,976,000 | 9,422,000 | 5,796,000 | 15,119,000 | 11,109,000 |
Depreciation Amortization | 5,291,000 | 3,473,000 | 1,747,000 | 7,009,000 | 5,193,000 |
Income taxes - deferred | -238,000 | -428,000 | 54,000 | -2,476,000 | -2,126,000 |
Accounts receivable | -366,000 | -403,000 | -790,000 | -309,000 | -680,000 |
Other Working Capital | -2,671,000 | -5,236,000 | -3,530,000 | 3,845,000 | 3,131,000 |
Other Operating Activity | 201,000 | -18,000 | 81,000 | 228,000 | 391,000 |
Operating Cash Flow | $15,193,000 | $6,810,000 | $3,358,000 | $23,416,000 | $17,018,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,924,000 | -1,200,000 | -608,000 | -233,000 | 865,000 |
Net Acquisitions | -949,000 | -949,000 | -939,000 | -5,810,000 | -5,562,000 |
Purchase Of Investment | -16,243,000 | -8,551,000 | -2,064,000 | -3,920,000 | -2,684,000 |
Sale Of Investment | 6,585,000 | 2,417,000 | 1,544,000 | 3,387,000 | 2,459,000 |
Other Investing Activity | -391,000 | 180,000 | 1,486,000 | 382,000 | 72,000 |
Investing Cash Flow | $-12,922,000 | $-8,103,000 | $-581,000 | $-6,194,000 | $-4,850,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 3,335,000 | 2,717,000 | 10,000 | 39,000 | 148,000 |
Debt Issued | 7,431,000 | 1,000 | 0 | 3,000 | 1,000 |
Debt Repayment | -562,000 | -11,000 | -11,000 | -2,823,000 | -1,008,000 |
Common Stock Issued | 922,000 | 708,000 | 332,000 | 954,000 | 580,000 |
Common Stock Repurchased | -2,900,000 | -2,417,000 | -1,711,000 | -6,746,000 | -6,320,000 |
Dividend Paid | -7,823,000 | -5,164,000 | -2,505,000 | -9,917,000 | -7,417,000 |
Other Financing Activity | -879,000 | -506,000 | -430,000 | 475,000 | 73,000 |
Financing Cash Flow | $-476,000 | $-4,672,000 | $-4,315,000 | $-18,015,000 | $-13,943,000 |
Exchange Rate Effect | -135,000 | -166,000 | -237,000 | -9,000 | -83,000 |
Beginning Cash Position | 17,305,000 | 17,305,000 | 17,305,000 | 18,107,000 | 18,107,000 |
End Cash Position | 18,965,000 | 11,174,000 | 15,530,000 | 17,305,000 | 16,249,000 |
Net Cash Flow | $1,660,000 | $-6,131,000 | $-1,775,000 | $-802,000 | $-1,858,000 |
Free Cash Flow | |||||
Operating Cash Flow | 15,193,000 | 6,810,000 | 3,358,000 | 23,416,000 | 17,018,000 |
Capital Expenditure | -2,024,000 | -1,287,000 | -625,000 | -3,498,000 | -2,238,000 |
Free Cash Flow | 13,169,000 | 5,523,000 | 2,733,000 | 19,918,000 | 14,780,000 |